| Source HCPCS Code |
|
Target NDC Code |
C9165
Injection, elranatamab-bcmm, 1 mg
|
⇄
|
00069-2522-01
ELREXFIO 4
|
| Detail Information |
| Relationship Start Date |
01/01/2024 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.000 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
C9165
Injection, elranatamab-bcmm, 1 mg
|
⇄
|
00069-2522-02
ELREXFIO 44 MG/1.1 ML VIAL
|
| Detail Information |
| Relationship Start Date |
01/01/2024 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1.1 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
C9165
Injection, elranatamab-bcmm, 1 mg
|
⇄
|
00069-4494-01
ELREXFIO 4
|
| Detail Information |
| Relationship Start Date |
01/01/2024 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.000 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
C9165
Injection, elranatamab-bcmm, 1 mg
|
⇄
|
00069-4494-02
ELREXFIO 76 MG/1.9 ML VIAL
|
| Detail Information |
| Relationship Start Date |
01/01/2024 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1.9 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
C9165
Inj, elranatamab-bcmm, 1 mg
|
⇄
|
00069-2522-02
Elrexfio
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
C9165
Inj, elranatamab-bcmm, 1 mg
|
⇄
|
00069-4494-02
Elrexfio
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|